⌘K

Login Start Free

Home/Filings/4/0000875320-08-000046

4//SEC Filing

VERTEX PHARMACEUTICALS INC / MA 4

Accession 0000875320-08-000046

$VRTXCIK 0000875320operating

View on SEC.gov Company Profile

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 11:21 AM ET

Size

11.3 KB

Accession

0000875320-08-000046

Insider Transaction Report

Form 4

Period: 2008-06-19

VERTEX PHARMACEUTICALS INC / MAVRTX

SVP, Drug Eval. & Appr.

Transactions

Exercise/Conversion
Common Stock
2008-06-19$15.87/sh+4,822$76,525→ 133,333 total
Exercise/Conversion
Stock Option
2008-06-19−4,822→ 0 total
Exercise: $15.87From: 2002-10-22Exp: 2012-07-21→ Common Stock (4,822 underlying)
Exercise/Conversion
Common Stock
2008-06-19$15.60/sh+3,459$53,960→ 136,792 total
Exercise/Conversion
Stock Option
2008-06-19−3,459→ 0 total
Exercise: $15.60From: 2003-04-18Exp: 2013-01-17→ Common Stock (3,459 underlying)

Holdings

Common Stock
(indirect: By 401(k))
5,140

Footnotes (1)

[F1]Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeoperating

IncorporatedMA

Related Parties

1

filerCIK 0000875320

Filing Metadata

Form type: 4
Filed: Jun 22, 8:00 PM ET
Accepted: Jun 23, 11:21 AM ET
Size: 11.3 KB

View on SEC.gov